Considerations for a Decentralized Manufacturing Paradigm

About the Author

Senior Manager - Global Regulatory Affairs CMC

Amgen Inc

Rita Algorri, PhD is a Senior Manager, Regulatory Affairs CMC at Amgen Inc. in Thousand Oaks, CA. In this role, her responsibilities include leading and...

Ting Wang, PhD

Sr. Principal Scientist

Amgen Inc

Ting Wang, PhD, is a Sr. Principal Scientist in the Process Development department at Amgen Inc and leads efforts to enhance raw material understanding and...

Jocelyn X. McQueen

Regulatory Affairs Leader Specializing in CMC Strategies

Amgen

Jocelyn X. McQueen, MS, is a regulatory affairs leader specializing in CMC strategies and submissions within the biopharmaceutical industry, with 15 years of experience spanning...

Nina S. Cauchon, PhD

Director Regulatory Affairs - CMC

Amgen Inc.

Nina S. Cauchon, Ph.D. is Director Regulatory Affairs CMC at Amgen Inc in Thousand Oaks, CA, and leads RA-CMC Advocacy and External Engagement. She has...

Features

Digital Display Labeling in Clinical Supplies for Clinical Trials

1 March 2024

Digital display labels (DDLs) offer an alternative solution to eliminate manual relabeling in the clinical supply chain, optimizing label content updates through a simple, system-controlled approach while providing new, uncharted opportunities. With increased efficiency in making regulatory-compliant changes and enhanced flexibility in the clinical supply chain, DDL technology has the...

Features

Evolving China’s Regulatory System in Alignment with ICH

1 March 2024

With the Chinese government initiating drug regulatory reform in 2015 and China joining the International Council for Harmonisation (ICH) in 2017, a significant number of measures have been implemented by the government. The aim is to make fundamental changes to China’s drug regulatory administration system so it can facilitate pharmaceutical development and better meet patient needs in the...

Features

Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact

1 March 2024

The Asia Pacific region (APAC), like any large territory, encompasses a blend of well-established and early-stage economies, diverse healthcare systems, and differences in language, culture, politics, and technology adoption. APAC’s size and complexity has created new challenges and opportunities for the pharmaceutical industry as nations work together to meet the manufacturing needs for...

About the Author

Facilities of the Future: Meeting the Demands of Breakthrough Therapeutics

Emerging Leader Hacker to GAMPer in 10 Weeks

New Initiative Seeks to Back up ICHs Harmonization Mission

Data Science-Assisted Biopharmaceutical Tech Transfer and Process Characterization

Entering a New Era of Innovation and Collaboration With the Focus on the Workforce of the Future

Q&A with ISPE Foundation Professional Development Grant Recipient Silas Tamufor

Related Articles